Aaron Schieving joined Lifecycle Biotechnologies in 2015 and as the VP, Sales and Marketing is responsible for the strategic development and management of the brands under the Lifecycle umbrella, Boval BioSolutions; a biologics manufacturing site, Chata Biosystems; a chemical, reagent, and media manufacturing site, and VI Plastics; a blow mold plastics manufacturing site. In this role Mr. Schieving also provides technical consultations on behalf of Boval, Chata, and VI Plastics focused on driving process improvements for each company’s customers. Mr. Schieving also serves as a member of the Lifecycle executive team. Previously, Mr. Schieving held roles with LABS, Inc. and Nelson Laboratories. Mr. Schieving's expertise spans multiple industries such as medical device, pharmaceuticals, organ and tissue, cell therapy and regenerative medicine and included advanced knowledge in microbiology and sterilization. Over the years Mr. Schieving has participated in numerous AATB committees and workgroups, include the Scientific Technical Affairs Committee (STAC), the Program Committee, and the Birth Tissue Workgroup.